Ranitidine hydrochloride and Cotrim drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine hydrochloride (ranitidine hydrochloride) and Cotrim (sulfamethoxazole; trimethoprim). Common drug interactions include toxic epidermal necrolysis among females and vomiting among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine hydrochloride and Cotrim. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine hydrochloride?

Ranitidine hydrochloride has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 76,413 Ranitidine hydrochloride users. Check the latest studies of Ranitidine hydrochloride.

What is Cotrim?

Cotrim has active ingredients of sulfamethoxazole; trimethoprim. eHealthMe is studying from 8,890 Cotrim users. Check the latest studies of Cotrim.



On Jul, 11, 2026

25 people who take Ranitidine hydrochloride and Cotrim together, and have interactions are studied.

Ranitidine hydrochloride and Cotrim drug interactions.

What are the common drug interactions of Ranitidine Hydrochloride and Cotrim, by gender? *:

female:

  1. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  2. Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits)
  3. Pyrexia (fever)
  4. Anaemia (lack of blood)
  5. Communication disorder (speech and language disorder)
  6. Cough
  7. Leukopenia (less number of white blood cells in blood)
  8. Memory impairment
  9. Metastases to central nervous system (cancer spreads to central nervous system)
  10. Mobility decreased (ability to move is reduced)

male:

  1. Vomiting
  2. Dyspnoea (difficult or laboured respiration)
  3. Activated partial thromboplastin time prolonged
  4. Anaemia (lack of blood)
  5. Anaemia neonatal
  6. Anger
  7. Anion gap increased
  8. Apgar score low
  9. Arthralgia (joint pain)
  10. Blood amylase increased

What are the common drug interactions of Ranitidine Hydrochloride and Cotrim, by age (0-1 to 60+)? *:

0-1:

  1. Anaemia neonatal
  2. Apgar score low
  3. Constipation
  4. Foetal growth retardation (a baby in the womb fails to grow at the expected rate during the pregnancy)
  5. Gastrointestinal malformation
  6. Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Premature baby
  9. Small for dates baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age)

2-9:

n/a

10-19:

  1. Grand mal convulsion (a type of generalized seizure that affects the entire brain)

20-29:

n/a

30-39:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Nausea (feeling of having an urge to vomit)
  4. Pneumonia fungal
  5. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  6. Rash
  7. Activated partial thromboplastin time prolonged
  8. Angiopathy (generic term for a disease of the blood vessels)
  9. Duodenitis (inflammation of the duodenum)
  10. Faeces discoloured

40-49:

  1. Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits)
  2. C-reactive protein increased
  3. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  4. Moyamoya disease (a disease in which certain arteries in the brain are constricted. blood flow is blocked by the constriction)
  5. Abdominal pain
  6. Anion gap increased
  7. Blood amylase increased
  8. Blood bicarbonate decreased
  9. Depressed level of consciousness
  10. Dyspnoea (difficult or laboured respiration)

50-59:

  1. Abdominal distension
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Atypical pneumonia (acute respiratory disease marked by high fever and coughing)
  4. Breath sounds decreased
  5. Cardiac murmur (an heart sound in valve abnormality)
  6. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  7. Hepatic failure (liver failure)
  8. Hepatic fibrosis (scarring process that represents the liver's response to injury)
  9. Inflammation
  10. Oedema peripheral (superficial swelling)

60+:

  1. Anaemia (lack of blood)
  2. Communication disorder (speech and language disorder)
  3. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
  4. Urinary retention (the inability to completely or partially empty the bladder)
  5. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  8. Hallucination (an experience involving the perception of something not present)
  9. Pruritus (severe itching of the skin)
  10. Skin disorder (skin disease)

What are the existing conditions these people have? *

  1. High Blood Pressure: 6 people, 24.00%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 20.00%
  3. Rickets (softening of bones): 4 people, 16.00%
  4. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 4 people, 16.00%
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 12.00%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 12.00%
  7. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 3 people, 12.00%
  8. Constipation: 3 people, 12.00%
  9. Pain: 2 people, 8.00%
  10. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine hydrochloride and Cotrim?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ranitidine hydrochloride and Cotrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ranitidine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cotrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranitidine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cotrim and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine hydrochloride and sulfamethoxazole; trimethoprim (the active ingredients of Ranitidine hydrochloride and Cotrim, respectively), and Ranitidine hydrochloride and Cotrim (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: